Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

GenoPalate

Explore full profile

GenoPalate analyzes genetic data, demographics and lifestyle information to deliver personalized insights for optimal healthy eating

Wauwatosa, United StatesFounded 2016Health Tech & Medtech
Valuation $10–25M Last recorded · 2024
Revenue $1–10M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for GenoPalate and the history behind them.

About GenoPalate

GenoPalate, founded in 2016 by Dr. Sherry Zhang, a molecular biologist, is a company that specializes in personalized nutrition based on an individual's genetic makeup. Dr. Zhang's research in obesity and metabolism led her to the conclusion that a one-size-fits-all approach to dieting is ineffective, which sparked the idea for GenoPalate. The company has since raised $15.4 million in funding to support its growth and development.

GenoPalate's primary offering is an at-home DNA testing kit that analyzes a person's genetic information to provide personalized dietary recommendations. The process begins with the customer providing a saliva sample, which is then sent to GenoPalate's lab for analysis. The company's proprietary algorithm, developed by a team of scientists and dietitians, analyzes over 100 genetic markers known to influence how the body processes food and nutrients. Based on this analysis, GenoPalate generates a comprehensive report that includes personalized recommendations for macronutrients, vitamins, and minerals, as well as a list of over 85 foods that are most compatible with the individual's genetic profile. The company also offers personalized recipes and supplements to complement its dietary recommendations.

GenoPalate operates on a direct-to-consumer business model, selling its DNA testing kits and personalized nutrition plans directly to customers through its website. The company also partners with healthcare professionals and corporate wellness programs to offer its services to a wider audience. GenoPalate's target market includes individuals who are looking to optimize their health, manage their weight, or address specific health concerns through a personalized approach to nutrition.

Source: Dealroom company data

At a glance

Founded
2016
Headquarters
Wauwatosa, United States
Sector
Health Tech & Medtech

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • gener8tor
  • BrightStar Wisconsin Foundation
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about GenoPalate on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See GenoPalate on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.